These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 10759209)

  • 41. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
    Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
    J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
    El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
    Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular characterization of the human neuropeptide Y Y2-receptor.
    Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG
    Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo.
    Mullins D; Kirby D; Hwa J; Guzzi M; Rivier J; Parker E
    Mol Pharmacol; 2001 Sep; 60(3):534-40. PubMed ID: 11502885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of NPY receptor subtypes Y2 and Y7 in rainbow trout Oncorhynchus mykiss.
    Larsson TA; Larson ET; Fredriksson R; Conlon JM; Larhammar D
    Peptides; 2006 Jun; 27(6):1320-7. PubMed ID: 16359756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor.
    St-Pierre JA; Dumont Y; Nouel D; Herzog H; Hamel E; Quirion R
    Br J Pharmacol; 1998 Jan; 123(2):183-94. PubMed ID: 9489605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR
    Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor.
    Kakui N; Tanaka J; Tabata Y; Asai K; Masuda N; Miyara T; Nakatani Y; Ohsawa F; Nishikawa N; Sugai M; Suzuki M; Aoki K; Kitaguchi H
    J Pharmacol Exp Ther; 2006 May; 317(2):562-70. PubMed ID: 16436501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
    Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
    Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy.
    Michel MC; Gaida W; Beck-Sickinger AG; Wieland HA; Doods H; Dürr H; Jung G; Schnorrenberg G
    Mol Pharmacol; 1992 Oct; 42(4):642-8. PubMed ID: 1331755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First selective agonist of the neuropeptide Y1-receptor with reduced size.
    Zwanziger D; Böhme I; Lindner D; Beck-Sickinger AG
    J Pept Sci; 2009 Dec; 15(12):856-66. PubMed ID: 19890892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-regulation of agonist activity at the Y receptors.
    Parker SL; Parker MS; Sah R; Balasubramaniam A; Sallee FR
    Peptides; 2007 Feb; 28(2):203-13. PubMed ID: 17194507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2-36[K4,RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake.
    McCrea K; Wisialowski T; Cabrele C; Church B; Beck-Sickinger A; Kraegen E; Herzog H
    Regul Pept; 2000 Feb; 87(1-3):47-58. PubMed ID: 10710288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards understanding the free and receptor bound conformation of neuropeptide Y by fluorescence resonance energy transfer studies.
    Haack M; Beck-Sickinger AG
    Chem Biol Drug Des; 2009 Jun; 73(6):573-83. PubMed ID: 19635049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropeptide Y induced attenuation of catecholamine synthesis in the rat mesenteric arterial bed.
    Westfall TC; Naes L; Gardner A; Yang CL
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):723-8. PubMed ID: 16810071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biophysical methods to study ligand-receptor interactions of neuropeptide Y.
    Bettio A; Beck-Sickinger AG
    Biopolymers; 2001; 60(6):420-37. PubMed ID: 12209475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.